Espero Biopharma logo

Espero BioPharma, Inc.

Espero is a biopharmaceutical company focusing on the late-stage development and commercialization of medicines to treat cardiovascular diseases, the leading cause of death worldwide. Recently, Espero merged with Armetheon, Inc., a privately-held, specialty pharmaceutical company developing innovative medicines, initially in thrombosis (tecarfarin) and cardiac arrhythmias (budiodarone).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://esperobio.com
Disease Focus
STOCK CODENon Listed
Address
14286-19 Beach Blvd #270, 32250
Jacksonville
United States
Email
Contact Number
+1 904-834-2665

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/espero-biopharma” connections=”true” suffix=””]